Skip to main content
Log in

IL-1 is an important mediator for microcirculatory changes in endotoxin-induced intestinal mucosal damage

  • Intestinal Disorders, Inflammatory Bowel Disease, And Irritable Bowel Syndrome
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Although small intestine is frequently injured in endotoxin shock, the exact pathological sequence has not been fully understood. The major objective of this study is to elucidate the role of interleukin (IL)-1 in endotoxin-induced microcirculatory disturbance of rat small intestine. Mucosal and submucosal microvessels of the rat ileum were observed by intravital microscope with a high speed video camera system and the attenuating effect of E5090, an inhibitor of IL-1 generation, on endotoxin-induced intestinal microcirculatory disturbances was investigated. Endotoxin infusion produced significant mucosal damage, but before these morphological changes became significant, microvascular stasis in villi, decreased red blood cell velocity, and increased leukocyte adherence to venular walls were observed in intestinal microcirculatory beds 30 min after endotoxin administration. Intestinal IL-1α levels were also significantly increased at that time. Endotoxin treatment enhanced chemiluminescence activity from neurophils and rapidly mobilized CD18 on leukocytes. E5090, which suppressed the IL-1 production in intestinal mucosa, attenuated the microcirculatory disturbances induced by endotoxin, and significantly reduced the subsequent mucosal damage. E5090 also attenuated the increased chemiluminescence activity and CD18 expression on leukocytes. In conclusion, the production of IL-1α is enhanced in the intestinal mucosa during endotoxin infusion. IL-1 may be an important mediator of microcirculatory changes, including decreased red blood cell velocity and increased leukocyte sticking and its activation, leading to the mucosal damage.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Svartholm E, Arvidsson S, Falt K, Haglund U: Influence of prostanoids on gastrointestinal mucosal injury in experimental septic shock. Acta Pathol Microbiol Immunol Scand 97:61–67, 1989

    Google Scholar 

  2. Dinarello CA, Gelfand JA, Wolff SM: Anticytokine strategies in the treatment of the systemic inflammatory response syndrome. JAMA 269:1829–1835, 1993

    PubMed  Google Scholar 

  3. Prabha PS, Das UN, Ramesh G, Kumar KV, Kamalakar V: Free radical generation, lipid peroxidation and essential fatty acids in patients with septicemia. Prostaglandin Leukotrienes Essent Fatty Acids 42:61–65, 1991

    Google Scholar 

  4. Ohlsson K, Bjork P, Bergenfeldt M, Hageman R, Thompson RC: Interleukin-1 receptor antagonist reduces mortality from endotoxin shock. Nature 348:550–552, 1990

    PubMed  Google Scholar 

  5. Wakabayashi G, Gelfand JA, Burke JF, Thompson RC, Dinarello CA: A specific receptor antagonist for interleukin-1 prevents E. coli-induced shock in rabbits. FASEB J 5:338–343, 1991

    PubMed  Google Scholar 

  6. di Giovine FS, Duff GW: Interleukin 1: The first interleukin. Immunol Today 11:13–20, 1990

    PubMed  Google Scholar 

  7. Dinarello CA: Interleukin-1 and interleukin-1 antagonism. Blood 77:1627–1652, 1991

    PubMed  Google Scholar 

  8. Oppenheim JJ, Matsushima K, Yoshimura T, Leonard EJ, Neta R: Relationship between interleukin 1 (IL1), tumor necrosis factor (TNF) and a neutrophil attracting peptide (NAP-1). Agents Actions 26:134–140, 1989

    PubMed  Google Scholar 

  9. Reinecker H-C, Loh EY, Ringler DJ, Mehta A, Rombeau JL, MacDermott RP: Monocyte-chemoattractant protein 1 gene expression in intestinal epithelial cells and inflammatory bowel disease mucosa. Gastroenterology 108:40–50, 1995

    PubMed  Google Scholar 

  10. Miura S, Imaeda H, Shiozaki H, Kurose I, Fukumura D, Tashiro H, Serizawa H, Suematsu M, Sekizuka E, Tsuchiya M: Attenuation of endotoxin-induced intestinal microcirculatory damage by eicosapentanoic acid. Am J Physiol 264 (Gastrointest Liver Physiol 27):G828-G834, 1993

    PubMed  Google Scholar 

  11. Goto M, Chiba K, Hashida R, Shirota H: In vitro inhibitory effects on the generation of IL-1 by human monocytes. Agents Actions (Suppl) 32:255–259, 1991

    Google Scholar 

  12. Shirota H, Chiba K, Goto M, Katayama K, Yamatsu I: Pharmacological properties of E5090. An orally active inhibitor of interleukin-1 generation.In Nonsteroidal Antiinflammatory Drugs, AJ Lewis, DE Furst (eds). New York, Marcel Dekker, 1994, pp 411–424

    Google Scholar 

  13. Kurose I, Anderson DC, Miyasaka M, Tamatani T, Paulson JC, Todd RF, Rusche JR, Granger DN: Molecular determinants of reperfusion-induced leukocyte adhesion and vascular protein leakage. Circ Res 74:336–343, 1994

    PubMed  Google Scholar 

  14. Kurose I, Wolf R, Anderson DC, Paulson JC, Miyasaka M, Granger DN: Inhibition of nitric oxide production. Mechanisms of vascular albumin leakage. Circ Res 73:164–171, 1993

    PubMed  Google Scholar 

  15. Kurose I, Suematsu M, Miura S, Fukumura D, Sekizuka E, Nagata H, Oshio C, Tsuchiya M: Oxyradical generation from leukocytes during endotoxin-induced microcirculatory disturbance in rat mesentery—Attenuating effect of cetraxate. Toxicol Appl Pharmacol 120:37–44, 1993

    PubMed  Google Scholar 

  16. Suematsu M, Kurose I, Asako H, Miura S, Tsuchiya M: In vivo visualization of oxyradical-dependent photoemission during endothelium-granulocyte interaction in microvascular beds treated with platelet-activating factor. J Biochem 106:355–360, 1989

    PubMed  Google Scholar 

  17. Granger DN, Schmid-Schönbein GW: Physiology and Pathophysiology of Leukocyte Adhesion. New York, Oxford University Press, 1995

    Google Scholar 

  18. Bohlen HG, Henrich H, Gore RW, Johnson PC: Intestinal muscle and mucosal blood flow during direct sympathetic stimulation. Am J Physiol 235 (Heart Circ Physiol 4): H40-H45, 1978

    PubMed  Google Scholar 

  19. Tashiro H, Miura S, Kurose I, Fukumura D, Suzuki H, Suematsu M, Yoshioka M, Tsuchiya M, Kai A, Kudoh Y: Verotoxin induces hemorrhagic lesions in rat small intestine. Temporal alteration of vasoactive substances. Dig Dis Sci 39:1230–1238, 1994

    PubMed  Google Scholar 

  20. Nishida T, Nishino N, Takano M, Sekiguchi Y, Kawai K, Mizuno K, Nakai S, Masui Y, Hirai Y: Molecular cloning and expression of rat interleukin-1α cDNA. J Biochem 105:351–357, 1989

    PubMed  Google Scholar 

  21. Clark BD, Bedrosian I, Schindler R, Cominelli F, Cannon JG, Shaw AR, Dinarello CA: Detection of interleukin 1α and 1β in rabbit tissues during endotoxemia using sensitive radioimmunoassays. J Appl Physiol 71:2412–2418, 1991

    PubMed  Google Scholar 

  22. Pizarro TT, Malinowska K, Kovacs EJ, Clancy J Jr, Robinson JA, Piccinini LA: Induction of TNF-α and TNF-β gene expression in rat cardiac transplants during allograft rejection. Transplantation 56:399–404, 1993

    PubMed  Google Scholar 

  23. Mester M, Tompkins RG, Gelfand JA, Dinarello CA, Burke JF, Clark BD: Intestinal production of interleukin-1α during endotoxemia in the mouse. J Surg Res 54:584–591, 1993

    PubMed  Google Scholar 

  24. Radema SA, VanDeventer SJH, Cerami A: Interleukin 1β is expressed predominantly by enterocytes in experimental colitis. Gastroenterology 100:1180–1186, 1990

    Google Scholar 

  25. Rachmilewitz D, Simon PL, Schwartz LW, Griswold DE, Fondacaro JD, Wasserman MA: Inflammatory mediators of experimental colitis in rats. Gastroenterology 97:326–337, 1989

    PubMed  Google Scholar 

  26. McCall RD, Haskill S, Zimmermann EM, Lund PK, Thompson RC, Sartor RB: Tissue interleukin 1 and interleukin-1 receptor antagonist expression in enterocolitis in resistant and susceptible rats. Gastroenterology 106:960–972, 1994

    PubMed  Google Scholar 

  27. Mahida YR, Wu K, Jewell DP: Enhanced production of interleukin 1β by mononuclear cells isolated from mucosa with active ulcerative colitis or Crohn's disease. Gut 30:835–838, 1989

    PubMed  Google Scholar 

  28. Reinecker H-C, Steffen M, Witthoeft T, Pflueger I, Schreiber S, MacDermott RP, Raedler A: Enhanced secretion of tumor necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease. Clin Exp Immunol 94:174–181, 1993

    PubMed  Google Scholar 

  29. Stevens C, Walz G, Singaram C, Lipman ML, Zanker B, Muggia A, Antonioli D, Peppercorn MA, Strom TB: Tumor necrosis factor-α, interleukin-1β and interleukin 6 expression in inflammatory bowel disease. Dig Dis Sci 37:818–826, 1992

    PubMed  Google Scholar 

  30. Alexander HR, Doherty GM, Venzon DJ, Merino MJ, Fraker DL, Norton JA: Recombinant interleukin-1 receptor antagonist (IL-1ra): Effective therapy against gram-negative sepsis in rats. Surgery 112:188–194, 1992

    PubMed  Google Scholar 

  31. Cominelli F, Nast CC, Clark BD, Schindler R, Lierena R, Eysselein VE, Thompson RC, Dinarello CA: Interleukin 1 (IL-1) gene expression, synthesis, and effect of specific IL-1 receptor blockade in rabbit immune complex colitis. J Clin Invest 86:972–980, 1990

    PubMed  Google Scholar 

  32. Detmers PA, Powell DE, Waltz A, Clark-Lewis I, Baggiolini M, Cohn ZA: Differential effects of neutrophil-activating peptide 1/IL-8 and its homologues on leukocyte adhesion and phagocytosis. J Immunol 147:4211–4217, 1991

    PubMed  Google Scholar 

  33. Mantovani A, Dejana E: Cytokines as communication signals between leukocytes and endothelial cells. Immunol Today 10:371–375, 1989

    Google Scholar 

  34. Xu H, Gonzalo JA, Pierre YS, Williams IR, Kupper TS, Cotran RS, Springer TA, Gutierrez-Ramos J-C: Leukocytosis and resistance to septic shock in intercellular adhesion molecule 1-deficient mice. J Exp Med 180:95–109, 1994

    PubMed  Google Scholar 

  35. Gonzalez-Crussi F, Hsueh W: Experimental model of ischemic bowel necrosis: The role of platelet-activating factor and endotoxin. Am J Pathol 112:127–135, 1983

    PubMed  Google Scholar 

  36. Miura S, Kurose I, Fukumura D, Suematsu M, Sekizuka E, Tashiro H, Serizawa H, Asako H, Tsuchiya M: Ischemic bowel necrosis induced by endothelin-1: An experimental model in rats. Digestion 48:163–172, 1991

    PubMed  Google Scholar 

  37. Sample AK, Czuprynski CJ: Priming and stimulation of bovine neutrophils by recombinant human interleukin-1 alpha and tumor necrosis factor alpha. J Leukoc Biol 49:107–115, 1991

    PubMed  Google Scholar 

  38. Ferrante A, Nandoskar M, Walz A, Goh DH, Kowanko IC: Effects of tumor necrosis factor alpha and interleukin-1 alpha and beta on human neutrophil migration, respiratory burst and degranulation. Int Arch Allergy Appl Immunol 86:82–91, 1988

    PubMed  Google Scholar 

  39. Suzuki H, Suematsu M, Miura S, Liu YY, Watanabe K, Miyasaka M, Tsurufuji S, Tsuchiya M: Rat CINC/gro: A novel mediator for locomotive and secretagogue activation of neutrophils in vivo. J Leukoc Biol 55:652–657, 1994

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fukumura, D., Miura, S., Kurose, I. et al. IL-1 is an important mediator for microcirculatory changes in endotoxin-induced intestinal mucosal damage. Digest Dis Sci 41, 2482–2492 (1996). https://doi.org/10.1007/BF02100147

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02100147

Key words

Navigation